Exploiting methionine restriction for cancer treatment - PubMed
Review
Exploiting methionine restriction for cancer treatment
Sushma Chaturvedi et al. Biochem Pharmacol. 2018 Aug.
Abstract
Normal cells can synthesize sufficient methionine for growth requirements from homocysteine and 5-methyltetrahydrofolate and vitamin B12. However, many cancer-cell types require exogenous methionine for survival and therefore methionine restriction is a promising avenue for treatment. While the lack of the methionine salvage enzyme methylthioadenosine phosphorylase (MTAP) deficiency is associated with methionine dependence in cancer cells, there are other causes for tumors to require exogenous methionine. In this review we describe studies that show restricting methionine to certain cancers by diet or by enzyme depletion, alone or in combination with certain chemotherapeutics is a promising antitumor strategy. The basis for methionine dependence in tumor cells is also briefly reviewed.
Keywords: 5-Methyltetrahydrofolate; MTAP; Methioninase; Methionine; Methionine restriction; Vitamin B12.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Methods to Study the Role of Methionine-Restricted Diet and Methioninase in Cancer Growth Control.
Chaturvedi S, Bertino JR. Chaturvedi S, et al. Methods Mol Biol. 2019;1866:1-12. doi: 10.1007/978-1-4939-8796-2_1. Methods Mol Biol. 2019. PMID: 30725403
-
Hori H, Tran P, Carrera CJ, Hori Y, Rosenbach MD, Carson DA, Nobori T. Hori H, et al. Cancer Res. 1996 Dec 15;56(24):5653-8. Cancer Res. 1996. PMID: 8971171
-
Cavuoto P, Fenech MF. Cavuoto P, et al. Cancer Treat Rev. 2012 Oct;38(6):726-36. doi: 10.1016/j.ctrv.2012.01.004. Epub 2012 Feb 17. Cancer Treat Rev. 2012. PMID: 22342103 Review.
-
Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.
Bertino JR, Waud WR, Parker WB, Lubin M. Bertino JR, et al. Cancer Biol Ther. 2011 Apr 1;11(7):627-32. doi: 10.4161/cbt.11.7.14948. Epub 2011 Apr 1. Cancer Biol Ther. 2011. PMID: 21301207 Free PMC article. Review.
Cited by
-
The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Zhang R, Noordam L, Ou X, Ma B, Li Y, Das P, Shi S, Liu J, Wang L, Li P, Verstegen MMA, Reddy DS, van der Laan LJW, Peppelenbosch MP, Kwekkeboom J, Smits R, Pan Q. Zhang R, et al. Liver Int. 2021 Jan;41(1):206-219. doi: 10.1111/liv.14692. Epub 2020 Oct 20. Liver Int. 2021. PMID: 33084231 Free PMC article.
-
Malin D, Lee Y, Chepikova O, Strekalova E, Carlson A, Cryns VL. Malin D, et al. Breast Cancer Res Treat. 2021 Dec;190(3):373-387. doi: 10.1007/s10549-021-06398-y. Epub 2021 Sep 22. Breast Cancer Res Treat. 2021. PMID: 34553295 Free PMC article.
-
The pancreatic cancer genome revisited.
Hayashi A, Hong J, Iacobuzio-Donahue CA. Hayashi A, et al. Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):469-481. doi: 10.1038/s41575-021-00463-z. Epub 2021 Jun 4. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34089011 Review.
-
Polyamine metabolism and cancer: treatments, challenges and opportunities.
Casero RA Jr, Murray Stewart T, Pegg AE. Casero RA Jr, et al. Nat Rev Cancer. 2018 Nov;18(11):681-695. doi: 10.1038/s41568-018-0050-3. Nat Rev Cancer. 2018. PMID: 30181570 Free PMC article. Review.
-
B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease.
Lyon P, Strippoli V, Fang B, Cimmino L. Lyon P, et al. Nutrients. 2020 Sep 19;12(9):2867. doi: 10.3390/nu12092867. Nutrients. 2020. PMID: 32961717 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources